Sample Name
Sample Code
Sample Name
Sample Code
Sample Name
Sample Code
4
BIDU-SW
09888
5
JD HEALTH
06618
| (Q3)Sep 30, 2025 | (Q2)Jun 30, 2025 | (Q1)Mar 31, 2025 | (FY)Dec 31, 2024 | (Q4)Dec 31, 2024 | (Q3)Sep 30, 2024 | (Q2)Jun 30, 2024 | (Q1)Mar 31, 2024 | (FY)Dec 31, 2023 | (Q4)Dec 31, 2023 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Total revenue | 71.47%141.7M | 124.50%126.99M | 160.81%150.31M | 26.17%286.98M | 61.70%94.26M | 31.38%82.64M | -4.86%56.57M | 23.10%57.63M | 26.91%227.46M | 29.45%58.29M |
| Cost of revenue | 87.21%109.83M | 130.11%91.64M | 160.80%111.7M | 17.90%205.09M | 49.12%65.45M | 20.35%58.67M | -14.41%39.83M | 23.17%42.83M | 29.42%173.94M | 30.87%43.89M |
| Gross profit | 32.96%31.87M | 111.17%35.35M | 160.83%38.61M | 53.03%81.9M | 100.04%28.81M | 69.39%23.97M | 29.53%16.74M | 22.92%14.8M | 19.40%53.52M | 25.31%14.4M |
| Operating expense | 11.83%15.99M | 73.88%16.76M | 101.89%18.27M | 25.06%44M | 59.25%15.33M | 45.04%14.3M | 25.83%9.64M | 17.63%9.05M | 20.98%35.18M | 18.01%9.63M |
| Selling and administrative expenses | -4.34%16.6M | 70.67%17.16M | 104.55%19.05M | 38.00%47.94M | 47.12%13.5M | 68.71%17.36M | 25.32%10.06M | 28.50%9.31M | 15.70%34.74M | 9.52%9.18M |
| -General and administrative expense | -4.34%16.6M | 70.67%17.16M | 104.55%19.05M | 38.00%47.94M | 47.12%13.5M | 68.71%17.36M | 25.32%10.06M | 28.50%9.31M | 15.70%34.74M | 9.52%9.18M |
| Other operating expenses | ---- | --205K | --311K | -46.95%1.06M | 9.31%1.81M | 9,620.00%972K | ---- | ---- | 137.96%1.99M | 123.20%1.65M |
| Total other operating income | -84.77%614K | 45.67%606K | 315.27%1.09M | 222.98%4.99M | -101.58%-19K | 816.14%4.03M | -25.31%416K | 91.24%262K | -13.08%1.55M | 25.12%1.21M |
| Operating profit | 64.19%15.88M | 161.80%18.59M | 253.53%20.34M | 106.70%37.9M | 182.30%13.48M | 125.33%9.67M | 34.90%7.1M | 32.28%5.75M | 16.49%18.33M | 43.20%4.77M |
| Net non-operating interest income (expenses) | -355.28%-906K | -5,207.14%-1.43M | -24,025.00%-965K | 17.41%-898.73K | -9,000.00%-637K | 55.28%-199K | 106.26%28K | 97.88%-4K | 21.35%-1.09M | 81.38%-7K |
| Non-operating interest income | 80.99%257K | 6.60%210K | 59.62%166K | 11.68%553.01K | -18.37%120K | 91.89%142K | 79.09%197K | -36.59%104K | 17.87%495.18K | -5.84%147K |
| Non-operating interest expense | 241.06%1.16M | 870.41%1.64M | 947.22%1.13M | -8.31%1.45M | 391.56%757K | -34.30%341K | -69.66%169K | -69.41%108K | -12.22%1.58M | -20.50%154K |
| Net investment income | ||||||||||
| Gain(Loss) on financial instruments designated as cash flow hedges | ||||||||||
| Gain(Loss) on derecognition of available-for-sale financial assets | ||||||||||
| Income from associates and other participating interests | 132.14%195K | 116.76%93K | 88.30%-11K | -250.81%-836.29K | -119.50%-62K | -54.10%84K | -444.12%-555K | -160.65%-94K | 2,333.00%554.54K | 1,039.88%318K |
| Special income (charges) | -514.62%-1.43M | 231.34%344.01K | ||||||||
| Less:Write off | ---- | ---- | ---- | 514.62%1.43M | ---- | ---- | ---- | ---- | -231.34%-344.01K | ---- |
| Other non-operating income (expenses) | ||||||||||
| Income before tax | 58.73%15.17M | 162.45%17.25M | 242.40%19.37M | 91.44%34.74M | 151.29%12.78M | 137.12%9.56M | 39.44%6.57M | 31.05%5.66M | 25.71%18.15M | 51.06%5.09M |
| Income tax | 7.07%3.51M | 146.32%4.72M | 204.65%5.64M | 174.00%12.03M | 202.61%4.75M | 605.59%3.28M | 54.10%1.92M | 66.16%1.85M | -0.38%4.39M | 62.08%1.57M |
| Net income | 85.74%11.66M | 169.09%12.53M | 260.76%13.73M | 65.07%22.7M | 128.38%8.03M | 76.02%6.28M | 34.18%4.66M | 18.83%3.81M | 37.18%13.75M | 46.60%3.52M |
| Net income continuous operations | 85.74%11.66M | 169.09%12.53M | 260.76%13.73M | 65.07%22.7M | 128.38%8.03M | 76.02%6.28M | 34.18%4.66M | 18.83%3.81M | 37.18%13.75M | 46.60%3.52M |
| Noncontrolling interests | 5,432.00%1.38M | 8,770.59%1.51M | 7,828.57%1.67M | 2,332.26%701.64K | 8,587.50%679K | 525.00%25K | 342.86%17K | -47.50%21K | 352.80%28.85K | -109.46%-8K |
| Net income attributable to the company | 64.35%10.27M | 137.57%11.02M | 218.76%12.06M | 60.31%22M | 108.60%7.35M | 75.51%6.25M | 33.42%4.64M | 19.67%3.78M | 36.74%13.72M | 52.31%3.52M |
| Preferred stock dividends | ||||||||||
| Other under preferred stock dividend | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Net income attributable to common stockholders | 64.35%10.27M | 137.57%11.02M | 218.76%12.06M | 60.31%22M | 108.60%7.35M | 75.51%6.25M | 33.42%4.64M | 19.67%3.78M | 36.74%13.72M | 52.31%3.52M |
| Gross dividend payment | ||||||||||
| Basic earnings per share | 63.92%0.0159 | 137.50%0.0171 | 216.95%0.0187 | 60.09%0.0341 | 107.27%0.0114 | 76.36%0.0097 | 33.33%0.0072 | 20.41%0.0059 | 36.54%0.0213 | 52.78%0.0055 |
| Diluted earnings per share | 59.79%0.0155 | 133.56%0.0168 | 216.95%0.0187 | 60.09%0.0341 | 107.27%0.0114 | 76.36%0.0097 | 33.20%0.0072 | 20.41%0.0059 | 36.54%0.0213 | 53.33%0.0055 |
| Dividend per share | 0.01 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0.01 | 0 |
| Accounting Standards | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP |
FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.
Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.